Compare Blue Owl Capital Inc. Class A Common Stock (OWL) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blue Owl Capital Inc. Class A Common Stock vs Tenet Healthcare Corporation — how do they compare? Blue Owl Capital Inc. Class A Common Stock trades at $8.79 (market cap $6.01B), while Tenet Healthcare Corporation trades at $271.76 (market cap $21.87B). The key difference: Tenet Healthcare Corporation is far larger — about 3.6× Blue Owl Capital Inc. Class A Common Stock's market cap, and Blue Owl Capital Inc. Class A Common Stock pays a 10.35% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Blue Owl Capital Inc. Class A Common Stock for 0 Days and Tenet Healthcare Corporation for 16 Days on average.
| OWL | THC | |
|---|---|---|
Market Cap | $6.01B | $21.87B |
Volume | 24,327,195 | 717,275 |
Sector | Financials | Health |
52-Week High | $17.17 | $280.77 |
52-Week Low | $8.23 | $161.37 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $10.19B | $32.95B |
Dividend Yield | 10.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Blue Owl Capital (OWL) trades at $9.29, down 0.54% on the day, with neutral technical indicators showing support at $9 and resistance at $10. The company reported mixed quarterly earnings, beating expectations in Q4 2025 and Q2 2026 but missing in Q1 2026, with Q3 2026 results pending. Revenue growth remains steady at $2.9B in 2025, projected to $3.0B in 2026, though net margins are thin at 2.71%. Analyst sentiment is positive with 63% buy ratings and a $11.01 consensus target, but private credit fund redemptions and loan quality concerns present headwinds.
OWL offers value at a discount to analyst targets with strong institutional backing, but investors face risks from high P/E valuation (77.42), exposure to private credit volatility, and competitive pressures. The stock's 9.8% dividend yield and embedded fee growth from $31.1B in committed capital support upside, though execution on portfolio quality and redemption management will dictate near-term performance. Neutral outlook with cautious optimism pending Q3 earnings clarity.
Tenet Healthcare (THC) trades at $266.91, down 0.69% on the day, with strong fundamental performance including three consecutive quarterly earnings beats. The stock maintains bullish technical signals with key support at $265 and resistance at $271. Revenue growth continues despite softer surgical volumes, driven by higher revenue per case and favorable service mix. Analyst consensus remains overwhelmingly positive with 81% buy ratings and a $283.36 price target representing 6% upside potential.
THC presents a compelling investment case with attractive valuation metrics (P/E 10.5, EV/EBITDA 5.91) and strong profitability (ROE 53.31%, net margin 9.9%). The company's expanding capital-return strategy is supported by robust cash flow, though growth investments and capital needs require monitoring. Key risks include execution challenges and healthcare regulatory uncertainty, but the fundamental outlook remains positive with expected revenue growth to $22.6B and net profit margin expansion to 9.89% in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Blue Owl Capital Inc. Class A Common Stock
Blue Owl Capital Inc. is an alternative asset manager that invests across credit, real assets, and GP strategic capital strategies, providing private capital solutions to businesses and to institutional and individual investors.
Read more on OWL →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
